XBiotech Inc (XBIT)
6.83
+0.21
(+3.17%)
USD |
NASDAQ |
Nov 22, 16:00
6.88
+0.05
(+0.73%)
After-Hours: 20:00
XBiotech Total Assets (Quarterly): 209.85M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 209.85M |
| June 30, 2024 | 215.56M |
| March 31, 2024 | 227.86M |
| December 31, 2023 | 226.62M |
| September 30, 2023 | 229.60M |
| June 30, 2023 | 235.14M |
| March 31, 2023 | 242.12M |
| December 31, 2022 | 246.10M |
| September 30, 2022 | 250.83M |
| June 30, 2022 | 266.46M |
| March 31, 2022 | 270.80M |
| December 31, 2021 | 275.18M |
| September 30, 2021 | 279.52M |
| June 30, 2021 | 353.96M |
| March 31, 2021 | 355.94M |
| December 31, 2020 | 353.74M |
| September 30, 2020 | 353.39M |
| June 30, 2020 | 358.76M |
| March 31, 2020 | 358.37M |
| December 31, 2019 | 816.88M |
| September 30, 2019 | 66.64M |
| Date | Value |
|---|---|
| June 30, 2019 | 71.88M |
| March 31, 2019 | 39.82M |
| December 31, 2018 | 44.34M |
| September 30, 2018 | 49.24M |
| June 30, 2018 | 54.29M |
| March 31, 2018 | 58.86M |
| December 31, 2017 | 62.97M |
| September 30, 2017 | 70.67M |
| June 30, 2017 | 77.84M |
| March 31, 2017 | 87.62M |
| December 31, 2016 | 67.05M |
| September 30, 2016 | 78.29M |
| June 30, 2016 | 93.20M |
| March 31, 2016 | 101.26M |
| December 31, 2015 | 109.36M |
| September 30, 2015 | 119.05M |
| June 30, 2015 | 126.85M |
| March 31, 2015 | 58.69M |
| December 31, 2014 | 62.18M |
| September 30, 2014 | 19.66M |
| December 31, 2013 | 11.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
209.85M
Minimum
Sep 2024
816.88M
Maximum
Dec 2019
306.33M
Average
268.63M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
| Oragenics Inc | 5.204M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.74M |
| Shareholders Equity (Quarterly) | 192.12M |